Commodore Capital’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$2.81M Hold
2023
Q1
$2.46M Hold
2022
Q4
$2.11M Hold
2022
Q3
$4.54M Hold
2022
Q2
$3.08M Hold
2022
Q1
$4.61M Hold
2021
Q4
$4.13M Hold
2021
Q3
$5.45M Buy
2021
Q2
$5.43M Buy
2021
Q1
$5.51M Buy